Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FUJSR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,122
Award facts
- Contract value 100% obligated
- $17,122.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 23, 2025, for the supply of Xolair 150 mg/ml auto-injectors, with a ceiling value of $17,122.20 and an ultimate completion date of October 15, 2025. This firm fixed-price delivery order represents no set-aside designation and is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499.999 billion through November 2026. The work will be performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters as a woman-owned small business pharmaceutical wholesaler.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. The company's Indefinite Delivery Contract with DLA under the SPE2DB program enables the issuance of delivery orders for comprehensive pharmaceutical products supporting Department of Defense medical supply needs globally. This particular delivery order for Xolair auto-injectors, a biologic medication used for asthma and allergic conditions, continues the company's established track record of providing specialized pharmaceutical products directly to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FUJSR?
SPE2DB25FUJSR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FUJSR worth?
The government has obligated $17,122 on SPE2DB25FUJSR.
Is contract SPE2DB25FUJSR an order under another contract?
Yes. SPE2DB25FUJSR is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJSR competed?
The extent of competition for SPE2DB25FUJSR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award